HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Indium-111 capromab pendetide in the management of recurrent prostate cancer.

Abstract
The provision of accurate prognostic information is a long-standing goal for effective management of prostate adenocarcinoma. Nontargeted imaging modalities are less efficient at detecting slow-growing prostate cancers. Prostate-specific membrane antigen has emerged as a superior biomarker, especially for the evaluation of metastatic spread. Advances in imaging technology have focused clinical interest on indium-111 capromab ((111)In capromab) pendetide, a radioimmunoconjugate that detects prostate-specific membrane antigen expression in vivo. Single-photon emission computed tomography capromab pendetide images, fused with those generated by computed tomography or magnetic resonance, have engendered improvements in localization accuracy by correlating high signal intensity with anatomic structures. In long-term outcomes studies, fused (111)In capromab pendetide scans have delivered significant benefits for patient selection and improved treatment of prostate cancer.
AuthorsMichael J Manyak
JournalExpert review of anticancer therapy (Expert Rev Anticancer Ther) Vol. 8 Issue 2 Pg. 175-81 (Feb 2008) ISSN: 1744-8328 [Electronic] England
PMID18279057 (Publication Type: Journal Article, Review)
Chemical References
  • Antibodies, Monoclonal
  • Indium Radioisotopes
  • Capromab Pendetide
  • Prostate-Specific Antigen
Topics
  • Adenocarcinoma (mortality, pathology, therapy)
  • Antibodies, Monoclonal
  • Combined Modality Therapy
  • Humans
  • Immunohistochemistry
  • Indium Radioisotopes
  • Male
  • Neoplasm Recurrence, Local (diagnostic imaging, mortality, therapy)
  • Neoplasm Staging
  • Prognosis
  • Prostate-Specific Antigen (blood)
  • Prostatic Neoplasms (mortality, pathology, therapy)
  • Sensitivity and Specificity
  • Survival Analysis
  • Tomography, Emission-Computed, Single-Photon
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: